Tracking growth hormone abuse in sport: A comparison of distinct isoform-based assays

Analytica Chimica Acta

Volumn 733, Issue , 2012, Pages 56-63

  Bosch, J ^a   Ueki, M ^c   Such Sanmartin G ^a   Segura, J ^a,b   Gutierrez Gallego R ^a,b  

^a Barcelona Biomedical Research Park   (Spain)

^b UNIVERSITAT POMPEU FABRA   (Spain)

^c Anti doping Research Laboratory   (Japan)

Author keywords

Doping; Growth hormone; Immunoassay; Isoform; Marker proteins

Indexed keywords

COMPLEX BINDING; CONCENTRATION MEASURES; DOPING CONTROL; GROWTH HORMONES; HUMAN GROWTH HORMONE; IMMUNOASSAY; ISOFORMS; MARKER PROTEINS; PEARSON CORRELATION; RECOMBINANT HUMAN GROWTH HORMONE (RHGH); TIME FRAME; WASH OUT;

ANTIBODIES; BINDING ENERGY; CORRELATION METHODS; DOPING (ADDITIVES); SPORTS; SURFACE PLASMON RESONANCE;

ASSAYS;

HUMAN GROWTH HORMONE; MONOCLONAL ANTIBODY;

ANTIGEN BINDING; ARTICLE; CONTROLLED STUDY; DOPING; HUMAN; HUMAN EXPERIMENT; IMMUNOASSAY; INTERMETHOD COMPARISON; ISOFORM DIFFERENTIAL IMMUNOASSAY; ISOFORM IMMUNOASSAY; MALE; NORMAL HUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SURFACE PLASMON RESONANCE;

ANTIBODIES, MONOCLONAL; DOPING IN SPORTS; HUMAN GROWTH HORMONE; HUMANS; IMMUNOASSAY; MALE; PROTEIN ISOFORMS; RECOMBINANT PROTEINS; SINGLE-BLIND METHOD; SUBSTANCE ABUSE DETECTION; SURFACE PLASMON RESONANCE;

EID: 84862495522     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2012.04.028     Document Type: Article

References (41)

1. World Anti-Doping Agency, The 2012 Prohibited List. International Standard, WADA (2012) (Last accessed time, March 2012). http://www.wada-ama.org/Documents/World_Anti-Doping_Program/WADP-Prohibited-list/2012/WADA_Prohibited_List_2012_EN.pdf.
2. Segura J., Gutierrez-Gallego R., Ventura R., Pascual J.A., Bosch J., Such-Sanmartin G., et al. Growth hormone in sport: beyond Beijing 2008. Ther. Drug Monit. 2009, 31:3-13.
3. Ehrnborg C., Bengtsson B.A., Rosen T. Growth hormone abuse. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 2000, 14:71-77.
4. Holt R.I., Sonksen P.H. Growth hormone, IGF-I and insulin and their abuse in sport. Br. J. Pharmacol. 2008, 154:542-556.
5. Lewis U.J., Bonewald L.F., Lewis L.J. The 20,000-dalton variant of human growth hormone: location of the amino acid deletions. Biochem. Biophys. Res. Commun. 1980, 92:511-516.
6. DeNoto F.M., Moore D.D., Goodman H.M. Human growth hormone DNA sequence and mRNA structure: possible alternative splicing. Nucleic Acids Res. 1981, 9:3719-3730.
7. Baumann G. Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. Endocr. Rev. 1991, 12:424-449.
8. Diaz M.J., Dominguez F., Haro L.S., Ling N., Devesa J. A 12-kilodalton N-glycosylated growth hormone-related peptide is present in human pituitary extracts. J. Clin. Endocrinol. Metab. 1993, 77:134-138.
9. Haro L.S., Lewis U.J., Garcia M., Bustamante J., Martinez A.O., Ling N.C. Glycosylated human growth hormone (hGH): a novel 24 kDa hGH-N variant. Biochem. Biophys. Res. Commun. 1996, 228:549-556.
10. Garcia-Barros M., Costoya J.A., Rios R., Arce V., Devesa J. N-glycosylated variants of growth hormone in human pituitary extracts. Horm. Res. 2000, 53:40-45.
11. Giorgianni F., Beranova-Giorgianni S., Desiderio D.M. Identification and characterization of phosphorylated proteins in the human pituitary. Proteomics 2004, 4:587-598.
12. Zhan X., Giorgianni F., Desiderio D.M. Proteomics analysis of growth hormone isoforms in the human pituitary. Proteomics 2005, 5:1228-1241.
13. Beranova-Giorgianni S., Zhao Y., Desiderio D.M., Giorgianni F. Phosphoproteomic analysis of the human pituitary. Pituitary 2006, 9:109-120.
14. Popii V., Baumann G. Laboratory measurement of growth hormone. Clin. Chim. Acta 2004, 350:1-16.
15. Sonksen P.H. Insulin, growth hormone and sport. J. Endocrinol. 2001, 170:13-25.
16. McHugh C.M., Park R.T., Sonksen P.H., Holt R.I. Challenges in detecting the abuse of growth hormone in sport. Clin. Chem. 2005, 51:1587-1593.
17. Baumann G., Stolar M.W., Buchanan T.A. The metabolic clearance, distribution, and degradation of dimeric and monomeric growth hormone (GH): implications for the pattern of circulating GH forms. Endocrinology 1986, 119:1497-1501.
18. Wu Z., Bidlingmaier M., Dall R., Strasburger C.J. Detection of doping with human growth hormone. Lancet 1999, 353:895.
19. Bidlingmaier M., Wu Z., Strasburger C.J. Test method: GH. Baillieres Best Pract. Res. Clin. Endocrinol. Metab. 2000, 14:99-109.
20. Bidlingmaier M., Strasburger C.J. Technology insight: detecting growth hormone abuse in athletes. Nat. Clin. Pract. Endocrinol. Metab. 2007, 3:769-777.
21. Bidlingmaier M., Suhr J., Ernst A., Wu Z., Keller A., Strasburger C.J., et al. High-sensitivity chemiluminescence immunoassays for detection of growth hormone doping in sports. Clin. Chem. 2009, 55:445-453.
22. Hashimoto Y., Ikeda I., Ikeda M., Takahashi Y., Hosaka M., Uchida H., et al. Construction of a specific and sensitive sandwich enzyme immunoassay for 20kDa human growth hormone. J. Immunol. Methods 1998, 221:77-85.
23. Ikeda I., Kono N., Makino T., Hashimoto Y. Monoclonal antibody specific for 20K human growth hormone and a cell line producing the monoclonal antibody. Patent 1997, 1-12. 876042.
24. Tsushima T., Katoh Y., Miyachi Y., Chihara K., Teramoto A., Irie M., et al. Serum concentration of 20K human growth hormone (20K hGH) measured by a specific enzyme-linked immunosorbent assay. Study group of 20K hGH. J. Clin. Endocrinol. Metab. 1999, 84:317-322.
25. Momomura S., Hashimoto Y., Shimazaki Y., Irie M. Detection of exogenous growth hormone (GH) administration by monitoring ratio of 20kDa- and 22kDa-GH in serum and urine. Endocr. J. 2000, 47:97-101.
26. Nelson A.E., Ueki M., Nguyen T.V., Leung K.C., Howe C.J., Trout G.J., et al. The influence of demographic factors on the ratio of 20-kDa and 22-kDa GH isoforms and the utility of the ratio for detection of GH doping in sport. Growth Horm. IGF Res. Conference Proceedings 2006, 16:S3.
27. Erotokritou-Mulligan I., Bassett E.E., Kniess A., Sonksen P.H., Holt R.I. Validation of the growth hormone (GH)-dependent marker method of detecting GH abuse in sport through the use of independent data sets. Growth Horm. IGF Res. 2007, 17:416-423.
28. Erotokritou-Mulligan I., Bassett E.E., Bartlett C., Cowan D., McHugh C., Seah R., et al. The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. J. Clin. Endocrinol. Metab. 2008, 93:2760-2763.
29. Erotokritou-Mulligan I., Bassett E.E., Cowan D.A., Bartlett C., McHugh C., Sonksen P.H., et al. Influence of ethnicity on IGF-I and procollagen III peptide (P-III-P) in elite athletes and its effect on the ability to detect GH abuse. Clin. Endocrinol. (Oxf.) 2009, 70:161-168.
30. Wu Z., Devany E., Balarini G., Junnila R., Bidlingmaier M., Strasburger C.J. Specific monoclonal antibodies and ultrasensitive immunoassays for 20K and 22K human growth hormone. Growth Horm. IGF Res. 2010, 20:239-244.
31. Sato M., Nozaki J., Shimazaki T., Takao Y., Otsuka Y., Ueki M. Isoform ratio of hGH in serum and new approach to automate array detection of proteins by means of flowcytometry. Proceedings of the Manfred Donike Workshop 23rd Cologne Workshop on Dope Analysis 2005 2005, 327-336. (Last accessed time December 2011). http://proceedings.live-record.de/proceedings_13_pdf/13_327.pdf, W. Schänzer, W. Geyer, A. Gotzmann, U. Mareck (Eds.).
32. Uchida H., Naito N., Asada N., Wada M., Ikeda M., Kobayashi H., et al. Secretion of authentic 20-kDa human growth hormone (20K hGH) in Escherichia coli and properties of the purified product. J. Biotechnol. 1997, 55:101-112.
33. Such-Sanmartin G., Bosch J., Segura J., Wu M., Du H., Chen G., et al. Characterisation of the 5kDa growth hormone isoform. Growth Factors 2008, 26:152-162.
34. Such-Sanmartin G., Bosch J., Segura J., Gutierrez-Gallego R. Generation of 5 and 17kDa human growth hormone fragments through limited proteolysis. Growth Factors 2009, 27:255-264.
35. Irie M., Ueki M., Kishikawa Y., Nishii M., Kawahara T. 20K-GH and its use in detecting GH abuse. Growth Horm. IGF Res. 2009, 19:352-356.
36. Leung K.C., Howe C., Gui L.Y., Trout G., Veldhuis J.D., Ho K.K. Physiological and pharmacological regulation of 20-kDa growth hormone. Am. J. Physiol. Endocrinol. Metab. 2002, 283:E836-E843.
37. World Anti-Doping Agency, hGH isoform differential immunoassays for anti-doping analyses. Guideline version 1.0 June 2010, WADA Version 1.0; June (2010) (Last accessed time March 2012) http://www.wada-ama.org/Documents/Resources/Guidelines/WADA_Guidelines_hGH%20Differential%20Immunoassays_EN_June10.pdf.
38. NIBSC, WHO International Standard Growth Hormone Human Pituitary, NIBSC Report code 80/505 (2007) 1-3 (Last accessed time March 2012). http://www.nibsc.ac.uk/documents/ifu/80-505.pdf.
39. Baumann G.P. Growth hormone isoforms. Growth Horm. IGF Res. 2009, 19:333-340.
40. Gutierrez-Gallego R., Bosch J., Such-Sanmartin G., Segura J. Surface plasmon resonance immuno assays - a perspective. Growth Horm. IGF Res. 2009, 19:388-398.
41. Okano M., Nishitani Y., Sato M., Ikekita A., Kageyama S. Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects. Drug Test Anal. 2010, 2:548-556.